Identification of potent natural compounds in targeting Leishmania major CYP51 and GP63 proteins using a high-throughput computationally enhanced screening
Abstract Background Leishmaniasis is a disease caused by protozoan forms called Leishmania which infect animals and humans. The drugs have been in use since half a century due to which there have been mutations in the microbe-facilitating drug resistance. So this provides a reason for searching for...
Main Authors: | Deepak A. Yaraguppi, Sanjay H. Deshpande, Zabin K. Bagewadi, Uday Muddapur, Sushil Anand, Santosh B. Patil |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-06-01
|
Series: | Future Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s43094-020-00038-w |
Similar Items
The role of parasite-derived arginase in murine Leishmania major
by: Muleme, Helen
Published: (2010)
by: Muleme, Helen
Published: (2010)
Similar Items
-
Response surface methodology-based optimization of biosurfactant production from isolated Bacillus aryabhattai strain ZDY2
by: Deepak A. Yaraguppi, et al.
Published: (2020-03-01) -
A combination DNA vaccine encoding nucleoside hydrolase 36 and glycoproteine 63 protects female but not male hamsters against Leishmania mexicana
by: Chalé-balboa W.G., et al.
Published: (2009-09-01) -
Impact of Leishmania Metalloprotease GP63 on Macrophage Signalling
by: Amandine eIsnard, et al.
Published: (2012-05-01) -
Structure and expression of GP63 genes in Leishmania major
by: Voth, Bevan Raymond
Published: (2009) -
Structure and expression of GP63 genes in Leishmania major
by: Voth, Bevan Raymond
Published: (2009)